PLK-1 [26], CDK-1 [27], PIK3CA [28], ATF4 [23], TEAD4 [29] and ALYREF [30] could enhance MYCN protein stability and sustain MYCN expression in neuroblastoma. This evidence concerns the gene MYCN and neuroblastoma.